McKesson Co. (NYSE:MCK) Shares Bought by RFG Advisory LLC

RFG Advisory LLC raised its position in McKesson Co. (NYSE:MCK) by 16.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,890 shares of the company’s stock after acquiring an additional 261 shares during the quarter. RFG Advisory LLC’s holdings in McKesson were worth $1,015,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Sachetta LLC acquired a new position in McKesson in the 4th quarter valued at about $27,000. BKM Wealth Management LLC acquired a new position in McKesson in the 4th quarter valued at about $31,000. Richardson Financial Services Inc. acquired a new position in shares of McKesson during the fourth quarter worth about $31,000. Carolinas Wealth Consulting LLC grew its position in shares of McKesson by 42.9% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 80 shares of the company’s stock worth $37,000 after buying an additional 24 shares in the last quarter. Finally, ICA Group Wealth Management LLC acquired a new position in shares of McKesson during the fourth quarter worth about $40,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In other news, EVP Thomas L. Rodgers sold 789 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $557.40, for a total transaction of $439,788.60. Following the completion of the sale, the executive vice president now owns 7,909 shares in the company, valued at $4,408,476.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Susan R. Salka sold 606 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $558.04, for a total transaction of $338,172.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas L. Rodgers sold 789 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $557.40, for a total value of $439,788.60. Following the sale, the executive vice president now owns 7,909 shares of the company’s stock, valued at approximately $4,408,476.60. The disclosure for this sale can be found here. Insiders sold 25,814 shares of company stock worth $14,511,649 over the last 90 days. 0.21% of the stock is currently owned by insiders.

McKesson Trading Down 0.0 %

Shares of NYSE MCK opened at $603.08 on Friday. McKesson Co. has a twelve month low of $395.30 and a twelve month high of $606.32. The stock has a 50 day moving average of $558.51 and a two-hundred day moving average of $520.18. The stock has a market cap of $78.39 billion, a P/E ratio of 26.95, a P/E/G ratio of 1.41 and a beta of 0.47.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $6.18 earnings per share for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). McKesson had a net margin of 0.97% and a negative return on equity of 245.88%. The firm had revenue of $76.36 billion during the quarter, compared to analysts’ expectations of $79.32 billion. During the same quarter in the prior year, the firm posted $7.19 EPS. McKesson’s quarterly revenue was up 10.8% compared to the same quarter last year. As a group, research analysts predict that McKesson Co. will post 31.54 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be paid a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date of this dividend is Monday, June 3rd. McKesson’s dividend payout ratio is currently 11.08%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. TD Cowen boosted their price objective on McKesson from $563.00 to $652.00 and gave the stock a “buy” rating in a research report on Wednesday, May 8th. Morgan Stanley boosted their price objective on McKesson from $522.00 to $548.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. StockNews.com cut McKesson from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 18th. Robert W. Baird boosted their target price on McKesson from $603.00 to $671.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. Finally, Evercore ISI boosted their target price on McKesson from $590.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. Two research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $571.47.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.